CARA logo

Cara Therapeutics (CARA) Retained Earnings

Annual Retained Earnings

-$684.75 M
-$118.51 M-20.93%

31 December 2023

CARA Retained Earnings Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Retained Earnings

-$747.93 M
-$12.48 M-1.70%

30 September 2024

CARA Quarterly Retained Earnings Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CARA Retained Earnings Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-20.9%-14.6%
3 y3 years-74.5%-67.2%
5 y5 years-132.6%-101.0%

CARA Retained Earnings High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-74.5%at low-67.2%at low
5 y5 years-132.6%at low-101.0%at low
alltimeall time-1189.2%at low-1159.5%at low

Cara Therapeutics Retained Earnings History

DateAnnualQuarterly
Sept 2024
-
-$747.93 M(+1.7%)
June 2024
-
-$735.46 M(+2.8%)
Mar 2024
-
-$715.44 M(+4.5%)
Dec 2023
-$684.75 M(+20.9%)
-$684.75 M(+5.0%)
Sept 2023
-
-$652.41 M(+4.5%)
June 2023
-
-$624.38 M(+5.3%)
Mar 2023
-
-$592.90 M(+4.7%)
Dec 2022
-$566.23 M(+17.8%)
-$566.23 M(+5.7%)
Sept 2022
-
-$535.89 M(+4.5%)
June 2022
-
-$512.71 M(+0.8%)
Mar 2022
-
-$508.51 M(+5.8%)
Dec 2021
-$480.76 M(+22.5%)
-$480.76 M(+7.5%)
Sept 2021
-
-$447.38 M(+0.2%)
June 2021
-
-$446.36 M(+7.4%)
Mar 2021
-
-$415.62 M(+5.9%)
Dec 2020
-$392.32 M(-2.1%)
-$392.32 M(-16.7%)
Sept 2020
-
-$471.23 M(+3.6%)
June 2020
-
-$454.72 M(+5.8%)
Mar 2020
-
-$429.65 M(+7.2%)
Dec 2019
-$400.73 M(+36.1%)
-$400.73 M(+7.7%)
Sept 2019
-
-$372.12 M(+9.7%)
June 2019
-
-$339.27 M(+7.3%)
Mar 2019
-
-$316.31 M(+7.5%)
DateAnnualQuarterly
Dec 2018
-$294.35 M(+33.6%)
-$294.35 M(+7.5%)
Sept 2018
-
-$273.70 M(+7.6%)
June 2018
-
-$254.30 M(+7.3%)
Mar 2018
-
-$237.11 M(+7.6%)
Dec 2017
-$220.34 M(+35.9%)
-$220.34 M(+6.9%)
Sept 2017
-
-$206.16 M(+6.4%)
June 2017
-
-$193.72 M(+5.0%)
Mar 2017
-
-$184.42 M(+13.7%)
Dec 2016
-$162.17 M(+54.6%)
-$162.17 M(+15.7%)
Sept 2016
-
-$140.20 M(+9.0%)
June 2016
-
-$128.66 M(+11.3%)
Mar 2016
-
-$115.58 M(+10.2%)
Dec 2015
-$104.89 M(+30.8%)
-$104.89 M(+10.0%)
Sept 2015
-
-$95.36 M(+5.3%)
June 2015
-
-$90.57 M(+6.7%)
Mar 2015
-
-$84.89 M(+5.8%)
Dec 2014
-$80.20 M(+28.4%)
-$80.20 M(+5.5%)
Sept 2014
-
-$76.03 M(+9.4%)
June 2014
-
-$69.48 M(+5.5%)
Mar 2014
-
-$65.84 M(+5.4%)
Dec 2013
-$62.46 M(+5.2%)
-$62.46 M(+3.5%)
Sept 2013
-
-$60.36 M(+1.6%)
Dec 2012
-$59.38 M(+11.8%)
-$59.38 M
Dec 2011
-$53.11 M
-

FAQ

  • What is Cara Therapeutics annual retained earnings?
  • What is the all time high annual retained earnings for Cara Therapeutics?
  • What is Cara Therapeutics annual retained earnings year-on-year change?
  • What is Cara Therapeutics quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Cara Therapeutics?
  • What is Cara Therapeutics quarterly retained earnings year-on-year change?

What is Cara Therapeutics annual retained earnings?

The current annual retained earnings of CARA is -$684.75 M

What is the all time high annual retained earnings for Cara Therapeutics?

Cara Therapeutics all-time high annual retained earnings is -$53.11 M

What is Cara Therapeutics annual retained earnings year-on-year change?

Over the past year, CARA annual retained earnings has changed by -$118.51 M (-20.93%)

What is Cara Therapeutics quarterly retained earnings?

The current quarterly retained earnings of CARA is -$747.93 M

What is the all time high quarterly retained earnings for Cara Therapeutics?

Cara Therapeutics all-time high quarterly retained earnings is -$59.38 M

What is Cara Therapeutics quarterly retained earnings year-on-year change?

Over the past year, CARA quarterly retained earnings has changed by -$95.53 M (-14.64%)